24/09/2024 17:10
|
Medical, Health & Aged Care
− Approval Based on Results from Positive, Global, Phase 3 FRESCO-2 Trial
− FRUZAQLA (fruquintinib) is the First Novel Targeted Therapy in Japan for Metastatic Colorectal Cancer (mCRC)...